NASDAQ · Medical - Instruments & Supplies

Repligen Corporation (RGEN) Stock

$173.88 +6.13% NASDAQ: RGEN Healthcare

Valuation

MetricValue
Price$173.88
Market Cap$9.81B
P/E Ratio248.72
P/B Ratio4.91
P/S Ratio13.23
EPS (TTM)$0.86
52-Week High$198.87
52-Week Low$100.99
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE1.98%
ROA1.41%
ROCE2.32%
Gross Margin50.25%
Operating Margin8.81%
Net Margin5.29%
Debt/Equity0.33
Current Ratio8.36

Annual Financials (USD)

Metric20212022202320242025
Revenue$671.0M$802.0M$632.0M$634.0M$738.0M
Operating Profit$167.0M$225.0M$48.0M$-35.0M$60.0M
Net Profit$128.0M$186.0M$36.0M$-26.0M$49.0M
EPS$2.24$3.24$0.63$-0.46$0.86
Op Margin24.9%28.0%7.5%-5.5%8.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.4B$2.5B$2.8B$2.8B$3.0B
Total Liabilities$608.0M$621.0M$866.0M$857.0M$844.0M
Cash$604.0M$523.0M$751.0M$757.0M$566.0M
Borrowings$366.0M$423.0M$712.0M$686.0M$690.0M

Latest News

Sector Update: Healthcare Stocks Softer Late Afternoon MT Newswires · Jul 22, 2026 Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach MarketBeat · Jul 22, 2026 Sector Update: Healthcare Stocks Lower in Afternoon Trading MT Newswires · Jul 22, 2026 Top Midday Stories: Trump Threatens Retaliation for Attacks in Strait of Hormuz; AMD to Supply MI450 GPUs to Anthropic MT Newswires · Jul 22, 2026 Sector Update: Healthcare Stocks Edge Higher Premarket Wednesday MT Newswires · Jul 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$119.0M$172.0M$114.0M$175.0M$117.0M
Investing Cash Flow$-288.0M$-367.0M$-162.0M$-119.0M$-322.0M
Financing Cash Flow$-3.0M$-17.0M$-42.0M$-17.0M$-18.0M
Net Cash Flow$-113.0M$-80.0M$228.0M$6.0M$-191.0M
Free Cash Flow$52.0M$39.0M$75.0M$142.0M$94.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.30
EV / EBITDA85.95
FCF Yield1.07%
Quick Ratio7.64
Interest Coverage2.95
Return 1Y16.50%
Return 3Y13.84%
Return 5Y-35.75%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAgilent Technologies, Inc. $170.54 +1.41% 33.95 $48.17B 0.59%
AVTRAvantor, Inc. $15.67 +1.82% -18.29 $10.60B 0.00%
BIOBio-Rad Laboratories, Inc. $366.16 +1.60% 44.31 $9.86B 0.00%
BLFSBioLife Solutions, Inc. $38.61 +0.00% 36.07 $1.89B 0.00%
MRVIMaravai LifeSciences Holdings, Inc. $7.44 +3.19% -14.75 $2.06B 0.00%

About Repligen Corporation

Repligen Corporation is led by CEO Olivier Loeillot, employs 2,000 people, headquartered in Waltham, US, publicly traded since 1986.

Repligen Corporation (RGEN) stock trades at $173.88 with a market capitalization of $9.81B. The stock is valued at a price-to-earnings (P/E) ratio of 248.72, price-to-book of 4.91, price-to-sales of 13.23. Over the past 52 weeks the stock has ranged between $100.99 and $198.87, and currently trades 12.6% below its 52-week high.

On profitability, Repligen Corporation generates a return on equity (ROE) of 1.98%, return on capital employed of 2.32%, an operating margin of 8.81%, a net profit margin of 5.29%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.31 +0.33% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.67 +1.27%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides